First-pass extracted concept

genetic engineering techniques for studying cannabinoid functions in rodents

Candidate: concept label1 source documents5 linked claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

The chapter describes a toolbox of genetic engineering approaches used in rodents to investigate cannabinoid effects and endocannabinoid system function. It emphasizes genetically modified rodent models across neuronal and non-neuronal populations.

Source 1DOIPubMed

Resources required

Use of these approaches requires genetic engineering techniques and genetically modified rodent models. The abstract also indicates application across multiple cell populations and tissues.

Source 1DOIPubMed

What problem it solves

These tools help researchers dissect ECS-related functions that are otherwise difficult to resolve because endocannabinoid enzymes and receptors have distinct and complex expression patterns.

Source 1DOIPubMed

What it does not solve

The abstract does not claim that any single genetic tool fully resolves all ECS functions or all pathological alterations linked to ECS dysregulation.

Source 1DOIPubMed

Alternatives

No specific alternative non-genetic approaches are named in the abstract.

Source 1DOIPubMed

Evidence Snippets

In this chapter, first, we take a critical look at the toolbox available to researchers who would like to investigate cannabinoid effects using genetic engineering techniques, then we comprehensively discuss genetically modified rodent models in various neuronal and non-neuronal cell populations, both within and outside the nervous system.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1biological rolesupports2026Source 1DOIPubMed

Endocannabinoids regulate physiological functions including learning and memory, stress and anxiety, feeding, energy balance, development, and ageing.

Claim 2biological rolesupports2026Source 1DOIPubMed

The endocannabinoid system is a major signalling system in the mammalian brain that regulates neurotransmission across numerous brain regions and cell populations.

Claim 3disease associationsupports2026Source 1DOIPubMed

Many CNS disorders, including schizophrenia, epilepsy, substance use disorders, and multiple sclerosis, are associated with dysregulation of the endocannabinoid system.

Claim 4research needsupports2026Source 1DOIPubMed

Discerning the physiological functions of endocannabinoid synthetic enzymes, degrading enzymes, and receptors is challenging because of their distinct and complex expression patterns.

Claim 5tool utilitysupports2026Source 1DOIPubMed

Genetic engineering techniques have shed light on complex endocannabinoid-system-related tasks.